SIM
AQST icon

Spark Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Spark Investment Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,300
Closed -$33K – 95
2020
Q1 		$33K Sell
15,300
-32,100
-68% -$122K 0.02% 329
2019
Q4 		$275K Buy
+47,400
New +$247K 0.03% 407
2019
Q2 		– Sell
-11,600
Closed -$80K – 565
2019
Q1 		$80K Buy
+11,600
New +$81.3K ﹤0.01% 590

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Spark Investment Management's AQST Position: Q2 2020 in Review

Spark Investment Management sold out of Aquestive Therapeutics (AQST) in Q2 2020, closing a stake of 15,300 shares — an estimated $33K sold.

Spark Investment Management first reported a position in AQST in Q1 2019 and held it in 3 quarters. The position peaked at $275K in Q4 2019. 57 funds tracked by Wall St. Rank hold AQST as of Q2 2020.

  • Spark Investment Management reported no remaining Aquestive Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 15,300 Aquestive Therapeutics shares in Q2 2020, an estimated $33K.
  • Spark Investment Management first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 3 quarters.
  • Spark Investment Management's Aquestive Therapeutics position peaked at $275K in Q4 2019.
  • 57 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.